Elevated copper and oxidative stress in cancer cells as a target for cancer treatment - PubMed (original) (raw)
Review
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al. Cancer Treat Rev. 2009 Feb.
Abstract
As we gain a better understanding of the factors affecting cancer etiology, we can design improved treatment strategies. Over the past three to four decades, there have been numerous successful efforts in recognizing important cellular proteins essential in cancer growth and therefore these proteins have been targeted for cancer treatment. However, studies have shown that targeting one or two proteins in the complex cancer cascade may not be sufficient in controlling and/or inhibiting cancer growth. Therefore, there is a need to examine features which are potentially involved in multiple facets of cancer development. In this review we discuss the targeting of the elevated copper (both in serum and tumor) and oxidative stress levels in cancer with the aid of a copper chelator d-penicillamine (d-pen) for potential cancer treatment. Numerous studies in the literature have reported that both the serum and tumor copper levels are elevated in a variety of malignancies, including both solid tumor and blood cancer. Further, the elevated copper levels have been shown to be directly correlated to cancer progression. Enhanced levels of intrinsic oxidative stress has been shown in variety of tumors, possibly due to the combination of factors such as elevated active metabolism, mitochondrial mutation, cytokines, and inflammation. The cancer cells under sustained ROS stress tend to heavily utilize adaptation mechanisms and may exhaust cellular ROS-buffering capacity. Therefore, the elevated copper levels and increased oxidative stress in cancer cells provide for a prospect of selective cancer treatment.
Similar articles
- Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Fang J, Seki T, Maeda H. Fang J, et al. Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302. doi: 10.1016/j.addr.2009.02.005. Epub 2009 Feb 26. Adv Drug Deliv Rev. 2009. PMID: 19249331 Review. - Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
Gupte A, Mumper RJ. Gupte A, et al. Free Radic Biol Med. 2007 Nov 1;43(9):1271-8. doi: 10.1016/j.freeradbiomed.2007.07.003. Epub 2007 Jul 13. Free Radic Biol Med. 2007. PMID: 17893040 - Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin--D-penicillamine conjugate.
Gupte A, Wadhwa S, Mumper RJ. Gupte A, et al. Bioconjug Chem. 2008 Jul;19(7):1382-8. doi: 10.1021/bc800042s. Epub 2008 Jun 21. Bioconjug Chem. 2008. PMID: 18570451 - Catalytic therapy of cancer by ascorbic acid involves redox cycling of exogenous/endogenous copper ions and generation of reactive oxygen species.
Hadi SM, Ullah MF, Shamim U, Bhatt SH, Azmi AS. Hadi SM, et al. Chemotherapy. 2010;56(4):280-4. doi: 10.1159/000319951. Epub 2010 Aug 11. Chemotherapy. 2010. PMID: 20714144 Review.
Cited by
- Review to Elucidate the Correlation between Cuproptosis-Related Genes and Immune Infiltration for Enhancing the Detection and Treatment of Cervical Cancer.
Pandey P, Ramniwas S, Pandey S, Lakhanpal S, Padmapriya G, Mishra S, Kaur M, Ashraf A, Kumar MR, Khan F. Pandey P, et al. Int J Mol Sci. 2024 Oct 1;25(19):10604. doi: 10.3390/ijms251910604. Int J Mol Sci. 2024. PMID: 39408933 Free PMC article. Review. - Copper homeostasis and cuproptosis in gynecological cancers.
Huang X, Lian M, Li C. Huang X, et al. Front Cell Dev Biol. 2024 Sep 25;12:1459183. doi: 10.3389/fcell.2024.1459183. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39386020 Free PMC article. Review. - Bis(amino acidato)copper(II) compounds in blood plasma: a review of computed structural properties and amino acid affinities for Cu2+ informing further pharmacological research.
Sabolović J. Sabolović J. Arh Hig Rada Toksikol. 2024 Sep 29;75(3):159-171. doi: 10.2478/aiht-2024-75-3871. eCollection 2024 Sep 1. Arh Hig Rada Toksikol. 2024. PMID: 39369326 Free PMC article. Review. - Rheumatoid arthritis and gliostatin: a two-sample Mendelian randomization analysis and RT-PCR validation.
Xia Z, Zong S, Zhou S, Rao Y, Li Z. Xia Z, et al. Clin Rheumatol. 2024 Oct 1. doi: 10.1007/s10067-024-07164-3. Online ahead of print. Clin Rheumatol. 2024. PMID: 39352437 - Exploring copper metabolism-induced cell death in gastric cancer: a single-cell RNA sequencing study and prognostic model development.
Chen Y, Liao Y, Huang L, Luo Z. Chen Y, et al. Discov Oncol. 2024 Sep 27;15(1):482. doi: 10.1007/s12672-024-01374-6. Discov Oncol. 2024. PMID: 39331287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous